GANT61 was able to efficiently block GLI1 as well as GLI2-induced transcription, IC50 is 5 μM[1].
Incubated with GANT61 (5 μM ;48 h) in PANC1 or 22Rv1 cells, the expression of GLI1 and PTCH was decreased[1]. In the Hh-responsive murine cell line C3H/10T1/2cell line, GANT61 (5/10μM ;48 h) dose-dependently suppressed endogenous Glil transcriptional upregulation induced by SHH treatment [2]. GANT61 treatment (20μM ;36h) abolished the clonogenicity of all six human colon carcinoma cell lines. Analysis of the molecular mechanisms of GANT61-induced cytotoxicity in HT29 cells showed increased Fas expression and decreased expression of PDGFRα[3]. GANT61 induced transient cellular accumulation at G(1)-S (24 hours) and in early S-phase (32 hours), with elevated p21(Cip1), cyclin E, and cyclin A in HT29 cells. GANT61 induced DNA damage within 24 hours, with the appearance of p-ATM and p-Chk2[4]. GANT61 induces cell death of SK-N-LO cells in a caspase-independent manner, by inhibiting DNA replication in the S phase[7]. GANT61 caused growth arrest and apoptosis in AML cells. Synergism effect between GANT61 and rapamycin was found in Kasumi-1, HL-60 and U937 cell lines[5].
GANT61(50 mg/kg; s.c.;16 days) induced tumor growth regression until no tumor was palpable in Human prostate cancer xenograft[1].GANT61(50 mg/kg; i.g. 12 days) enhanced the effects of chemotherapeutic drugs used in the treatment of neuroblastoma in an additive or synergistic manner and reduced the growth of established neuroblastoma xenografts in nude mice[6].
References:
[1]. Lauth M, Bergstr?m A,et,al. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8455-60. doi: 10.1073/pnas.0609699104. Epub 2007 May 9. PMID: 17494766; PMCID: PMC1866313.
[2]. Desch P, Asslaber D et,al.Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene. 2010 Sep 2;29(35):4885-95. doi: 10.1038/onc.2010.243. Epub 2010 Jul 5. PMID: 20603613.
[3]. Mazumdar T, DeVecchio J, et,al.Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res. 2011 Feb 1;71(3):1092-102. doi: 10.1158/0008-5472.CAN-10-2315. Epub 2010 Dec 6. PMID: 21135115; PMCID: PMC3032813.
[4]. Mazumdar T, Devecchio J, et,al. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res. 2011 Sep 1;71(17):5904-14. doi: 10.1158/0008-5472.CAN-10-4173. Epub 2011 Jul 11. PMID: 21747117; PMCID: PMC3165104.
[5]. Pan D, Li Y et,al. Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin. Leuk Res. 2012 Jun;36(6):742-8. doi: 10.1016/j.leukres.2012.02.012. Epub 2012 Mar 6. PMID: 22398221.
[6]. Wickstr?m M, Dyberg C, et,al.Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer. 2013 Apr 1;132(7):1516-24. doi: 10.1002/ijc.27820. Epub 2012 Oct 3. PMID: 22949014.
[7]. Matsumoto T, Tabata K, et,al.The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull. 2014;37(4):633-41. doi: 10.1248/bpb.b13-00920. PMID: 24694609.
GANT61 能够有效阻断 GLI1 和 GLI2 诱导的转录,IC50 为 5 μM[1]。
在 PANC1 或 22Rv1 细胞中与 GANT61 (5 μM ;48 h) 孵育后,GLI1 和 PTCH 的表达降低[1]。在 Hh 反应性小鼠细胞系 C3H/10T1/2 细胞系中,GANT61 (5/10μM ;48 h) 剂量依赖性地抑制由 SHH 处理诱导的内源性 Glil 转录上调 [2]。 GANT61 处理(20μM;36 小时)消除了所有六种人结肠癌细胞系的克隆形成。 GANT61 诱导 HT29 细胞毒性的分子机制分析表明,Fas 表达增加,PDGFRα 表达减少[3]。 GANT61 在 G(1)-S(24 小时)和早期 S 期(32 小时)诱导瞬时细胞积累,在 HT29 细胞中 p21(Cip1)、细胞周期蛋白 E 和细胞周期蛋白 A 升高。 GANT61 在 24 小时内诱导 DNA 损伤,并出现 p-ATM 和 p-Chk2[4]。 GANT61 通过抑制 S 期 DNA 复制,以不依赖半胱天冬酶的方式诱导 SK-N-LO 细胞死亡[7]。 GANT61 在 AML 细胞中引起生长停滞和细胞凋亡。在Kasumi-1、HL-60和U937细胞系[5]中发现GANT61与雷帕霉素有协同作用。
GANT61(50 mg/kg;皮下注射;16 天)诱导肿瘤生长消退,直到在人前列腺癌异种移植物中未触及肿瘤[1]。GANT61(50 mg/kg;即 12 天) )以相加或协同的方式增强化疗药物治疗神经母细胞瘤的作用,降低已建立的裸鼠神经母细胞瘤异种移植物的生长[6]。
















